April 21, 2024
1 minute read
Important points:
- Orthobond Corporation has received new FDA approval for its Ostaguard antimicrobial coating technology.
- Ostaguard features a non-leaching coating that kills bacteria that cause device-related infections.
According to a press release, Orthobond announced new FDA approval for Ostagard, an antimicrobial non-leaching coating technology that can be used on a variety of medical devices.
Ostaguard technology has a non-leaching coating that neutralizes bacteria that cause device-related infections, according to the release.
Ostagard is designed for procedures in joint reconstruction, neuromodulation, oncology, sports medicine, plastic surgery, and cardiology. According to the release, Ostagard may be used for non-medical antimicrobial purposes, including in textiles and consumer products.
“We are proud of our evidence-based submissions to the FDA and look forward to making our innovative technology available to a variety of customers.” david nichols Orthobond CEO said in a release. “We believe our surface coatings have the potential to become a standard of care for implantable devices to protect patients from pathogens, and this will revolutionize surgery and beyond.” Nichols he added.
